Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, L S
Right arrow Articles by Eliopoulos, A G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, L S
Right arrow Articles by Eliopoulos, A G
J Clin Pathol: Mol Pathol 2000; 53:238-247
© 2000 Journal of Clinical Pathology


Review

The expression and function of Epstein-Barr virus encoded latent genes

L S Young1, C W Dawson1 and A G Eliopoulos1

1 CRC Institute for Cancer Studies, University of Birmingham Medical School, Birmingham B15 2TA, UK

Correspondence: Professor Young L.S.Young{at}bham.ac.uk

The association of Epstein-Barr virus (EBV) with various malignancies is well established but the pattern of EBV latent gene expression in these different tumours is variable, reflecting distinct aspects of the virus–cell interaction. These different forms of EBV latency are associated with phenotypic variation and highlight the influence of EBV latent proteins on cell growth and survival. The EBV latent proteins have distinct functions associated with the maintenance of EBV infection and the control of various signalling and transcriptional pathways that facilitate the proliferation and survival of infected cells. Understanding the function of these EBV latent proteins will not only provide insight into the mechanisms governing fundamental cell processes but will also identify targets for novel treatment.

Key Words: Epstein-Barr virus • EBV latent genes




This article has been cited by other articles:


Home page
J. Virol.Home page
C. Le Clorennec, T.-S. Ouk, I. Youlyouz-Marfak, S. Panteix, C.-C. Martin, J. Rastelli, E. Adriaenssens, U. Zimber-Strobl, J. Coll, J. Feuillard, et al.
Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis
J. Virol., July 1, 2008; 82(13): 6721 - 6733.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Kaul, M. Murakami, T. Choudhuri, and E. S. Robertson
Epstein-Barr Virus Latent Nuclear Antigens Can Induce Metastasis in a Nude Mouse Model
J. Virol., October 1, 2007; 81(19): 10352 - 10361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Madureira, P. Matos, I. Soeiro, L. K. Dixon, J. P. Simas, and E. W.-F. Lam
Murine {gamma}-Herpesvirus 68 Latency Protein M2 Binds to Vav Signaling Proteins and Inhibits B-cell Receptor-induced Cell Cycle Arrest and Apoptosis in WEHI-231 B Cells
J. Biol. Chem., November 11, 2005; 280(45): 37310 - 37318.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Pages, J. Galon, G. Karaschuk, D. Dudziak, M. Camus, V. Lazar, S. Camilleri-Broet, C. Lagorce-Pages, S. Lebel-Binay, G. Laux, et al.
Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
Blood, February 15, 2005; 105(4): 1632 - 1639.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Lin, Q. Yin, and E. Flemington
Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1
J. Virol., November 1, 2004; 78(21): 11962 - 11971.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. Tune, M. Pilon, Y. Saiki, and H.-M. Dosch
Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation
J. Immunol., January 15, 2002; 168(2): 680 - 688.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
P G Murray and L S Young
Themed issue: the biology and pathology of the Epstein-Barr virus
Mol. Pathol., October 1, 2000; 53(5): 219 - 221.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.